Article
Men are more likely to stay the course of TNF inhibitor therapy.
Reference1. Rusman T, Ten Wolde S, Euser SM, et al. Gender differences in retention rate of tumor necrosis factor alpha inhibitor treatment in ankylosing spondylitis: a retrospective cohort study in daily practice. Int J Rheum Dis. 2018;21:836-842. doi: 10.1111/1756-185X.13271.